LivaNova (LIVN) Income from Non-Controlling Interests (2017)
LivaNova's (LIVN) quarterly Income from Non-Controlling Interests came in at $1.9 million in Q4 2017, up 334.82% quarter-over-quarter from -$830000.0 in Q3 2017.
Powered by 
Analysis
LivaNova (LIVN) Income from Non-Controlling Interests (2017) Analysis & Trends
LivaNova has disclosed Income from Non-Controlling Interests across 1 years of filings, most recently posting $1.9 million for Q4 2017.
- In Q4 2017, Income from Non-Controlling Interests changed N/A year-over-year to $1.9 million; the TTM figure through Dec 2017 stood at $1.3 million (changed N/A YoY), while the FY2017 annual figure was $1.3 million, down 98.03% from the prior year.
- Income from Non-Controlling Interests came in at $1.9 million for Q4 2017 at LivaNova, up from -$830000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $2.0 million in Q1 2017 to a low of -$1.8 million in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 1.95 Mn |
| Sep 30, 2017 | -830,000.00 |
| Jun 30, 2017 | -1.80 Mn |
| Mar 31, 2017 | 1.96 Mn |